Standout Papers
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack (2006)
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack (2010)
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI (2016)
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary (2006)
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation (2010)
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation (2011)
- Antithrombotic Therapy for Atrial Fibrillation (2012)
- Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation (2001)
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation (2011)
- American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (2003)
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation (2014)
- Antithrombotic Therapy in Atrial Fibrillation (2008)
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation (2013)
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (2011)
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2014)
- Atrial Fibrillation and Diabetes Mellitus (2019)
- Deep learning for cardiovascular medicine: a practical primer (2019)
- Machine learning prediction in cardiovascular diseases: a meta-analysis (2020)
Immediate Impact
2 by Nobel laureates 3 from Science/Nature 235 standout
Citing Papers
Materials-Driven Soft Wearable Bioelectronics for Connected Healthcare
2024 Standout
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
2020 Standout
Works of Jonathan L. Halperin being referenced
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation
2012
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jonathan L. Halperin | 28140 | 9327 | 5980 | 296 | 33.9k | |
| Michael D. Ezekowitz | 40498 | 13070 | 7523 | 264 | 46.7k | |
| Stuart J. Connolly | 42494 | 11551 | 5330 | 470 | 47.1k | |
| Robert G. Hart | 18243 | 5700 | 8570 | 226 | 25.3k | |
| Elaine M. Hylek | 23759 | 10794 | 4395 | 252 | 30.2k | |
| Basil S. Lewis | 18835 | 6722 | 2732 | 274 | 24.4k | |
| Harry J.G.M. Crijns | 35250 | 4113 | 3035 | 595 | 41.1k | |
| Robert M. Califf | 23485 | 6328 | 2884 | 305 | 29.7k | |
| Michael W. Rich | 20591 | 2221 | 4887 | 326 | 28.1k | |
| Deirdre A. Lane | 21425 | 6619 | 4173 | 307 | 24.6k | |
| Manesh R. Patel | 21648 | 6367 | 2987 | 526 | 29.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...